Brisbane MedTech Accelerator program success after the strength of Cardihab’s global potential recognised

Cardihab has been selected to participate in the Brisbane Economic Development Agencies (BEDA) MedTech accelerator program. Aimed at fast-tracking global investment and market entry for local MedTech organisations, the program is designed to connect startup or early-stage innovation companies with international capital funders and strategic partners.

Delivered in partnership with US based investment facilitator Life Science Nation, the BEDA MedTech accelerator cohort companies are invited to attend the global investor RESI Conference in San Francisco where they will pitch to active investors during JP Morgan Healthcare Week in January 2025.

Cardihab is committed to transformational change in the way that cardiac rehabilitation is equitably accessed and experienced for patients and clinicians, with the aim of impacting poor rates of participation and correlated health outcomes.

“We know there is significant need for a high quality, clinically validated solution like Cardihab, particularly in the US where the current cost of poor health outcomes for those with heart disease is in the vicinity of $1 billion per day,” says Cardihab CEO Helen Souris.

“We’re very happy to have been awarded the opportunity by BEDA to participate in this accelerator program, and the opportunity to meet with partners who can provide a pathway into these markets where the need for quality healthcare solutions is significant.”

Lord Mayor Adrian Schrinner says, “Brisbane is at the forefront of medical technology innovation globally and this year’s cohort represent the next wave of groundbreaking health solutions.”

“We are proud to support these businesses as they continue to innovate and make a positive impact on healthcare worldwide.